عن المؤلف

H. Schellekens is a recognized figure in the field of biopharmaceuticals, particularly known for his work on the antigenicity of rDNA-derived pharmaceuticals. His research has significantly contributed to understanding how antibodies interact with cytokines, which is crucial in developing effective therapies. Schellekens' publications, including titles like 'From Clone to Clinic,' delve into the complexities of therapeutic antibodies and their implications for clinical practice.